drugset / Trial / NCT01934582

A Pharmacokinetic Substudy of the TDE-PH-304 Protocol

NCT01934582

Phase 3 Completed 13 enrolled United Therapeutics
NaSingle-groupOpen-labelOther

Summary

A sub-study to the TDE-PH-304 protocol to assess the pharmacokinetics of patients transitioning from a twice daily dosing regimen of oral treprostinil to a three times daily dosing regimen.

Timeline

Start
2013-08
Primary completion
2013-11
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Treprostinil diethanolamine Unknown Oral